Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel vs Methotrexate in Recurrent/Metastatic SCCHN
NCT01528163Phase 2Completed
- Start
- Feb 2012
- Primary completion
- Nov 2014
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in squamous cell carcinoma of the head and neck (HNSCC). Started Feb 2012; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01528163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528163.